On March 22, 2011, Actavis Labs Fl Inc received FDA approval for ANDA090084, a generic drug anticipated to drive incremental sales in the specific therapeutic market while offering a cost-effective alternative to branded competitors.
On March 22, 2011, Actavis Labs Fl Inc received FDA approval for ANDA090084, a generic drug anticipated to drive incremental sales in the specific therapeutic market while offering a cost-effective alternative to branded competitors.